Allison M Bock

11PUBLICATIONS
92CO-AUTHORS
Liquid biopsiesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Aug 20, 2026
Second Line CD19 CAR-T vs Platinum Salvage and Autologous Stem Cell Transplant for Primary Mediastinal B-Cell Lymphoma.

|Jun 09, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.

|Dec 17, 2025
Cost-effectiveness of chimeric antigen receptor T-cell therapy for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis.

Taylor J Loftus, Jeong-Yeon Cho, Manuel Meraz

|Jul 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma.

Janek S Walker, Kerstin Wenzl, Joseph P Novak

|Nov 29, 2024
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance.

Allison M Bock, Kerstin Wenzl, Joseph P Novak

Pageof 2

Frequent Collaborators

4 joint publications

Thomas E Witzig

3 joint publications

Reem Karmali

3 joint publications

Matthew J Maurer

3 joint publications

James R Cerhan